|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs显示文摘 | Rogers JF Nafziger AN Jr Bertino JS | 2002 | Am J Med2002，113，15： | 1 |
| 2 | Limited sampling models for oral midazolam : midazolam plasma concentrations, not the ratio of 1-hydroxymidazolam to midazolam plasma concentrations, accurately predicts AUC as a biomarker of CYP3A activity 显示文摘 | Lee LS Bertino JS Jr Nafziger AN | 2006 | J Clin Pharmacol2006，46，： | 1 |
| 3 | American college of clinical pharmacology position statement on the use of microdosing in the drug development process 显示文摘 | BERTINO JS JR GREENBERG HE REED MD | 2007 | J Clin Pharmacol2007，47，4： | 1 |
| 4 | Gatifloxacin assosiated QT interval prolongation, torsades depointes,and ventricular fibrillation in pafionts with known risk factors显示文摘 | Bertino JS Jr Owens RC Jr Carnes TD | 2002 | Clin Infect Dis2002，34，6： | 1 |
| 5 | Gatifloxacin - associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors显示文摘 | Bertino JS Jr Owens RC Jr Carnes TD | 2002 | Clin Infect Dis2002，34，6： | 1 |
| 6 | Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers显示文摘 | Bertino JS Jr Nafziger AN | 1996 | Antimicrob Agents Chemother1996，40，3： | 1 |
| 7 | Incidence of and significant risk factors for aminoglycoside-associated nephrotoxity in patients dosed by using individualized pharmaticmonitoring 显示文摘 | Bertino JS Jr Booker LA Franck PA | 1993 | J Infect Dis1993，167，： | 1 |
| 8 | Gatifloxacin-associated corrected QT interval prolongation,torsades de pointes,and ventricular fibrillation in patients with known risk factors显示文摘 | Bertino JS Jr Owens RC Jr Carnes TD | 2002 | Clin Infect Dis2002，34，6： | 1 |
| 9 | Evaluation of in vi- vo P-glycoprotein phenotyping probes:a need for validation 显示文摘 | Ma JD Tsunoda SM Bertino JS Jr | 2010 | Clin Pharmacokinet2010，49，4： | 1 |
| 10 | Sex-related differences in theophylline pharmacokinetics显示文摘 | Bertino Jr JS | 1989 | Eur J Clin Pharmacol1989，37，： | 1 |
| 11 | Phenotyping of drug-metabolizing enzymes in adults:a review of in-vivo cytochrome P450 phenotyping probes显示文摘 | Streetman DS Bertino JS Jr Nafziger AN | 2000 | Pharmacogenetics2000，10，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员